CN101287473B - 包含疏水基团结合型糖胺聚糖在制备预防或治疗角膜上皮层病症的药物中的用途 - Google Patents

包含疏水基团结合型糖胺聚糖在制备预防或治疗角膜上皮层病症的药物中的用途 Download PDF

Info

Publication number
CN101287473B
CN101287473B CN2006800380199A CN200680038019A CN101287473B CN 101287473 B CN101287473 B CN 101287473B CN 2006800380199 A CN2006800380199 A CN 2006800380199A CN 200680038019 A CN200680038019 A CN 200680038019A CN 101287473 B CN101287473 B CN 101287473B
Authority
CN
China
Prior art keywords
administration
group
area
hydrophobic group
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2006800380199A
Other languages
English (en)
Chinese (zh)
Other versions
CN101287473A (zh
Inventor
宫本健司
高桥胜哉
下岛裕司
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seikagaku Corp
Original Assignee
Seikagaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Corp filed Critical Seikagaku Corp
Publication of CN101287473A publication Critical patent/CN101287473A/zh
Application granted granted Critical
Publication of CN101287473B publication Critical patent/CN101287473B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CN2006800380199A 2005-10-12 2006-10-12 包含疏水基团结合型糖胺聚糖在制备预防或治疗角膜上皮层病症的药物中的用途 Expired - Fee Related CN101287473B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2005297170 2005-10-12
JP297170/2005 2005-10-12
JP160478/2006 2006-06-09
JP2006160478 2006-06-09
PCT/JP2006/320801 WO2007043702A1 (en) 2005-10-12 2006-10-12 Agent for applying to mucosa and method for production thereof

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN201210562380.9A Division CN103120701B (zh) 2005-10-12 2006-10-12 包含疏水基团结合型糖胺聚糖在制备预防或治疗角膜上皮层病症的药物中的用途
CN201210562963.1A Division CN103120702B (zh) 2005-10-12 2006-10-12 包含疏水基团结合型糖胺聚糖在制备预防或治疗角膜上皮层病症的药物中的用途

Publications (2)

Publication Number Publication Date
CN101287473A CN101287473A (zh) 2008-10-15
CN101287473B true CN101287473B (zh) 2013-01-02

Family

ID=37942916

Family Applications (3)

Application Number Title Priority Date Filing Date
CN201210562963.1A Expired - Fee Related CN103120702B (zh) 2005-10-12 2006-10-12 包含疏水基团结合型糖胺聚糖在制备预防或治疗角膜上皮层病症的药物中的用途
CN2006800380199A Expired - Fee Related CN101287473B (zh) 2005-10-12 2006-10-12 包含疏水基团结合型糖胺聚糖在制备预防或治疗角膜上皮层病症的药物中的用途
CN201210562380.9A Expired - Fee Related CN103120701B (zh) 2005-10-12 2006-10-12 包含疏水基团结合型糖胺聚糖在制备预防或治疗角膜上皮层病症的药物中的用途

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201210562963.1A Expired - Fee Related CN103120702B (zh) 2005-10-12 2006-10-12 包含疏水基团结合型糖胺聚糖在制备预防或治疗角膜上皮层病症的药物中的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201210562380.9A Expired - Fee Related CN103120701B (zh) 2005-10-12 2006-10-12 包含疏水基团结合型糖胺聚糖在制备预防或治疗角膜上皮层病症的药物中的用途

Country Status (9)

Country Link
US (4) US20080306022A1 (enExample)
EP (1) EP1942912B1 (enExample)
JP (3) JP4387445B2 (enExample)
KR (4) KR101554834B1 (enExample)
CN (3) CN103120702B (enExample)
AU (1) AU2006300207C1 (enExample)
CA (1) CA2625532C (enExample)
ES (1) ES2616295T3 (enExample)
WO (1) WO2007043702A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
ES2616295T3 (es) * 2005-10-12 2017-06-12 Seikagaku Corporation Agente para aplicar a mucosa y procedimiento para la producción del mismo
WO2008069348A1 (en) 2006-12-06 2008-06-12 Seikagaku Corporation Pharmaceutical agent having long-lasting effect of treating arthritic disorders
JP2009046454A (ja) * 2007-08-22 2009-03-05 Shiseido Co Ltd 口腔内用組成物
ITMI20072237A1 (it) * 2007-11-27 2009-05-28 Sigea Srl Esteri misti butirrico-formico di polisaccaridi acidi, loro preparazione ed uso come dermocosmetici
JP5758797B2 (ja) 2008-04-04 2015-08-05 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション アルキル化半合成グリコサミノグリカンエーテルならびにその製造および使用方法
EP2360188B1 (en) 2008-11-05 2014-09-17 National University Corporation Tokyo Medical and Dental University Hyaluronic acid derivative and pharmaceutical composition thereof
FR2958646B1 (fr) 2010-04-07 2012-05-18 Adocia Polysaccharides comportant des groupes fonctionnels carboxyles substitues par un derive d'acide hydrophobe.
CA2703532C (en) * 2010-05-10 2018-05-01 Eva Turley Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
JP6062917B2 (ja) 2011-03-23 2017-01-18 ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション 泌尿器科の炎症の治療及び予防の方法
US9067299B2 (en) 2012-04-25 2015-06-30 Applied Materials, Inc. Printed chemical mechanical polishing pad
CN107106594A (zh) 2014-12-26 2017-08-29 生化学工业株式会社 改善眼的自觉症状的制剂和方法
CN104940221A (zh) * 2015-05-13 2015-09-30 北京大清生物技术有限公司 一种用于膀胱和尿道上皮损伤修复的组合物
WO2016194869A1 (ja) * 2015-05-29 2016-12-08 生化学工業株式会社 グリコサミノグリカン誘導体とケモカイン受容体活性調節材とを含む組成物
US20190008889A1 (en) * 2015-08-20 2019-01-10 Seikagaku Corporation Agent to be applied to ophthalmic device
US10525159B2 (en) 2016-05-26 2020-01-07 Ophtecs Corporation Liquid preparation for contact lenses comprising hydrolyzed hyaluronic acid derivative and cationic bactericide
WO2018053111A1 (en) 2016-09-15 2018-03-22 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
KR20190068575A (ko) * 2016-10-14 2019-06-18 이콤 메디칼 게엠베하 안구 표면 항상성의 확립, 회복 및 보존 방법
CN110891611B (zh) 2017-03-22 2024-03-29 阿森迪斯制药公司 水凝胶交联透明质酸前药组合物和方法
RU2652581C1 (ru) * 2017-07-03 2018-04-26 федеральное государственное бюджетное образовательное учреждение высшего образования "Приволжский исследовательский медицинский университет" Министерства здравоохранения Российской Федерации Способ лечения роговично-конъюнктивального ксероза
CN111228653A (zh) 2018-11-13 2020-06-05 格莱科米拉治疗公司 用电离辐射加强癌症治疗的方法
EP4039279A4 (en) 2019-10-03 2023-11-01 Seikagaku Corporation TRANSMUCOSAL MEDICINAL ACTIVE DELIVERY SYSTEM FOR THE BLADDER SUBMUCOSA

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01238530A (ja) 1988-03-17 1989-09-22 Seikagaku Kogyo Co Ltd 角膜上皮層障害症治療剤
JPH0673102A (ja) 1992-02-05 1994-03-15 Seikagaku Kogyo Co Ltd 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
JPH08143604A (ja) 1994-11-17 1996-06-04 Seikagaku Kogyo Co Ltd 光架橋性ヒアルロン酸誘導体とその架橋体およびそれらの製造方法
CN1128065A (zh) * 1994-03-14 1996-07-31 生化学工业株式会社 戴在眼球上的材料
WO1998029125A1 (fr) * 1996-12-27 1998-07-09 Seikagaku Corporation Remedes contre des troubles de la vessie
CN1207744A (zh) * 1995-11-15 1999-02-10 生化学株式会社 光固化交联透明质酸凝胶及其制备方法
WO2000001733A1 (en) * 1998-07-06 2000-01-13 Fidia Advanced Biopolymers S.R.L. Amides of hyaluronic acid and the derivatives thereof and a process for their preparation
WO2000056344A1 (fr) * 1999-03-24 2000-09-28 Seikagaku Corporation Salive artificielle
JP2002356447A (ja) * 2001-03-30 2002-12-13 Chisso Corp 婦人科疾患治療剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US5733892A (en) * 1990-07-24 1998-03-31 Seikagaku Corporation Metastasis inhibitor composition comprising a phospholipid-linked glycosaminoglycan and method for inhibiting metastasis employing the same
DE4203529A1 (de) * 1992-02-07 1993-08-12 Wolff Walsrode Ag Wasserloesliche sulfoalkylhydroxyalkylderivate der cellulose und deren verwendung in gips- und zementhaltigen massen
CA2162957C (en) * 1994-11-17 2011-08-02 Michinori Waki Cinnamic acid derivative
US6025444A (en) * 1994-11-17 2000-02-15 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Cinnamic acid derivative
JP3955107B2 (ja) * 1995-05-01 2007-08-08 生化学工業株式会社 架橋多糖の製造法
EP0763754B1 (en) * 1995-09-13 2003-01-08 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Photocured crosslinked-hyaluronic acid contact lens
JP4006039B2 (ja) * 1995-09-13 2007-11-14 生化学工業株式会社 光架橋ヒアルロン酸コンタクトレンズ
US6548487B2 (en) * 1996-12-27 2003-04-15 Seikagaku Corporation Agent for treatment of bladder troubles
JPH1171282A (ja) 1997-09-01 1999-03-16 Senju Pharmaceut Co Ltd 点眼用水性製剤
JP3014357B2 (ja) 1998-01-26 2000-02-28 生化学工業株式会社 角膜上皮層伸展促進剤
PT1142566E (pt) 2000-04-07 2004-02-27 Medidom Lab Formulacao oftalmica topica na forma de uma solucao aquosa e uso de uma ciclosporina em associacao com acido hialuronico ou um de seus sais e com polisorbato 80
JP2001329002A (ja) * 2000-05-25 2001-11-27 Denki Kagaku Kogyo Kk 修飾ヒアルロン酸ゲルとその製造方法及びそれを含有する医用材料
JP2002037746A (ja) 2000-07-24 2002-02-06 Fuji Yakuhin:Kk キノロンカルボン酸系抗菌剤を含有する液剤
JP4172176B2 (ja) 2000-12-19 2008-10-29 生化学工業株式会社 光反応性ヒアルロン酸およびその製造方法ならびに光架橋ヒアルロン酸および医用材料
DE60117502T2 (de) * 2000-12-19 2006-08-24 Seikagaku Corp. Photohärtbare Derivate von Hyaluronsäure, Verfahren zu deren Herstellung, vernetztes und photogehärtetes Derivat der Hyaluronsäure und diese enthaltendes medizinisches Material
CA2435637A1 (en) * 2001-01-23 2002-08-01 Massachusetts Institute Of Technology Solid- and solution -phase synthesis of heparin and other glycosaminoglycans
AU2005283282B2 (en) * 2004-09-15 2011-05-19 Seikagaku Corporation Photoreactive polysaccharide, photocrosslinked polysaccharide products, the method of making them and medical materials therefrom
ES2616295T3 (es) * 2005-10-12 2017-06-12 Seikagaku Corporation Agente para aplicar a mucosa y procedimiento para la producción del mismo
JP7023317B2 (ja) 2020-05-12 2022-02-21 沖電気工業株式会社 光波長フィルタ及び波長分離光回路

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01238530A (ja) 1988-03-17 1989-09-22 Seikagaku Kogyo Co Ltd 角膜上皮層障害症治療剤
JPH0673102A (ja) 1992-02-05 1994-03-15 Seikagaku Kogyo Co Ltd 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
CN1128065A (zh) * 1994-03-14 1996-07-31 生化学工业株式会社 戴在眼球上的材料
JPH08143604A (ja) 1994-11-17 1996-06-04 Seikagaku Kogyo Co Ltd 光架橋性ヒアルロン酸誘導体とその架橋体およびそれらの製造方法
CN1207744A (zh) * 1995-11-15 1999-02-10 生化学株式会社 光固化交联透明质酸凝胶及其制备方法
WO1998029125A1 (fr) * 1996-12-27 1998-07-09 Seikagaku Corporation Remedes contre des troubles de la vessie
WO2000001733A1 (en) * 1998-07-06 2000-01-13 Fidia Advanced Biopolymers S.R.L. Amides of hyaluronic acid and the derivatives thereof and a process for their preparation
WO2000056344A1 (fr) * 1999-03-24 2000-09-28 Seikagaku Corporation Salive artificielle
JP2002356447A (ja) * 2001-03-30 2002-12-13 Chisso Corp 婦人科疾患治療剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
孙秉基 等 主编.角膜病的理论基础与临床 第1版.科学技术文献出版社,1994,209-210. *

Also Published As

Publication number Publication date
CN101287473A (zh) 2008-10-15
CN103120702B (zh) 2014-11-05
EP1942912A4 (en) 2010-10-06
KR20140054368A (ko) 2014-05-08
US20110207695A1 (en) 2011-08-25
AU2006300207B2 (en) 2011-12-01
JP2009511423A (ja) 2009-03-19
CN103120701A (zh) 2013-05-29
HK1184700A1 (en) 2014-01-30
EP1942912A1 (en) 2008-07-16
KR20130109259A (ko) 2013-10-07
KR101411067B1 (ko) 2014-06-27
ES2616295T3 (es) 2017-06-12
US20150196574A1 (en) 2015-07-16
AU2006300207C1 (en) 2012-05-24
CA2625532C (en) 2013-10-01
US8969319B2 (en) 2015-03-03
CA2625532A1 (en) 2007-04-19
JP4387445B2 (ja) 2009-12-16
KR20080056012A (ko) 2008-06-19
EP1942912B1 (en) 2016-12-14
KR101554834B1 (ko) 2015-09-21
AU2006300207A1 (en) 2007-04-19
KR101428153B1 (ko) 2014-08-07
JP5094799B2 (ja) 2012-12-12
US20080306022A1 (en) 2008-12-11
HK1184701A1 (en) 2014-01-30
JP2012211171A (ja) 2012-11-01
WO2007043702A9 (en) 2007-06-07
CN103120702A (zh) 2013-05-29
WO2007043702A1 (en) 2007-04-19
CN103120701B (zh) 2014-11-05
US20180289730A1 (en) 2018-10-11
JP2009298798A (ja) 2009-12-24
KR20110120983A (ko) 2011-11-04

Similar Documents

Publication Publication Date Title
JP5094799B2 (ja) 粘膜適用剤及びその製造方法
JP3439481B2 (ja) 光架橋ヒアルロン酸ゲルおよびその製造法
WO2021147585A1 (zh) 含氟化合物修饰的壳聚糖作为药物载体的用途及其制备方法
JP2009511423A5 (enExample)
ES2905606T3 (es) Conjugados de hialuronano con sustancias farmacéuticamente activas, métodos y composiciones
ES2305897T3 (es) Proteccion de superficie de tejidos biologicos expuestos.
HK1184701B (en) Use of glycosaminoglycan containing a binded hydrophobic group in the preparation of medicine for treating or preventing corneal epithelial layer disorders
HK1184700B (en) Use of glycosaminoglycan containing a binded hydrophobic group in the preparation of medicine for treating or preventing corneal epithelial layer disorders
AU2012201314B2 (en) Agent for applying to mucosa and method for production thereof
RU2191782C2 (ru) Способ получения модифицированной гиалуроновой кислоты

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CI01 Publication of corrected invention patent application

Correction item: First inventor

Correct: Kenji Miyamoto

False: Miyamoto Kenji

Number: 01

Volume: 29

CI03 Correction of invention patent

Correction item: First inventor

Correct: Kenji Miyamoto

False: Miyamoto Kenji

Number: 01

Page: The title page

Volume: 29

ERR Gazette correction
RECT Rectification
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130102

CF01 Termination of patent right due to non-payment of annual fee